الفهرس 
Intr?du?ti?nOnly 14 pages are availabe for public view
 |  | from | 229 |  |  |
| | | from | 229 | | |
Abstract
Accurate radiologic assessment of treatment response in lymphoma patients is important to evaluate
the efectiveness of treatment and consequently predict the relapse; the value of PET/CT for post-treatment prognosis
prediction has been recently investigated. The aim of this study is to highlight the prognostic value of PET-CT metabolic volumetric parameters in the evaluation of lymphoma patients.
Results:
Among the included 40 patients, post-treatment SUV, MTV, and TLG were signifcantly lower in a responsive
group than the non-responsive group. % changes of all quantitative PET/CT parameters were signifcantly higher in
the responsive group than the non-responsive group.
Conclusions:
This study suggests that pre-treatment PET/CT quantitative measures (except baseline SUVmax) are
not conclusive in the prediction of patient response to treatment; however, the ΔSUVmax, ΔMTV, and ΔTLG% from
the baseline to the end of therapy could be used in predicting patient response to treatment, determining patient
prognosis, and suggesting the relapse.